Spots Global Cancer Trial Database for Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS)
Official Title: Multicenter Phase II Study With Bendamustin for Patients With Refractory Soft Tissue Sarcoma
Study ID: NCT00204620
Conditions
Interventions
Study Description
Brief Summary: The aims of this trial are to evaluate the efficacy of bendamustin in patients with metastatic soft tissue sarcoma who have progressed after or during an anthracycline-baesd chemotherapy and to assess the treatment of toxicity.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Medical center II, University of Tuebingen, Tuebingen, , Germany
Contact Details
Name: Joerg T Hartmann, MD
Affiliation: South West German Cancer Center, Medical Center II, University of Tuebingen
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
